Artivion Inc
AORT
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.41B
Close$
$-6.72
123.7% downside
Current Fair Value
123.7% downsideOvervalued by 123.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.41 Billion |
|---|---|
| Enterprise Value | $1.75 Billion |
| Dividend Yield | $0.12 (-) |
| Earnings per Share | $0.22 |
| Beta | 1.25 |
| Outstanding Shares | 48,541,000 |
Return
| Return on Equity | -0.71% |
|---|---|
| Return on Assets | -0.30% |
| Return on Invested Capital | 2.18% |
Valuation & Multiples
| P/E Ratio | -488.93 |
|---|---|
| PEG | 44.27 |
| Price to Sales | 3.16 |
| Price to Book Ratio | 3.16 |
| Enterprise Value to Revenue | 3.71 |
| Enterprise Value to EBIT | 83.14 |
| Enterprise Value to Net Income | -554 |
| Total Debt to Enterprise | 0.24 |
| Debt to Equity | 0.93 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$0.00
Average shareholder expectationRevenue Estimate
$119.99 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$0.11
Average shareholder expectationRevenue Estimate
$121.29 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Artivion Inc
1,200 employees
CEO: James Mackin Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. Cr...